NYSE:AbbVie

График котировок AbbVie


Добавить в список сравнения Добавить в список сравнения
Добавить в список отслеживания Добавить в список отслеживания

Основные параметры

Цена ао 102.7
P/E 21.73
P/S 3.97
P/BV 11.66
EV/EBITDA 16.83
Дивиденд ао 5.2
Див.доход ао 5.16
EBITDA 18.37

Основные владельцы

Institutions Объем Доля, %
First Trust Portfolios L.P. 771002 0.04
Guggenheim Funds Distributors, LLC 275 0
Invesco Capital Markets Inc 241 0
Advisors Asset Management, Inc. 395329 0.02
Sabrient Systems 87105 0
Fidelity Management & Research Company 46559381 3.15
BlackRock Fund Advisors 37829044 2.14
Transamerica Asset Management, Inc 3475145 0.2
Security Investors, LLC 396549 0.02
Putnam Investment Management, LLC 5519302 0.31
Hennion & Walsh, Inc 1000 0
WisdomTree Asset Management Inc 2325190 0.13
Orbis Investment Management Limited 6894487 0.47
SunAmerica Asset Management, LLC 6926243 0.47
Voya Investments, LLC 3527845 0.2
DWS Investment S.A. 2912187 0.16
Nordea Investment Management AB 2349547 0.13
Nuveen Fund Advisors, LLC. 2339950 0.13
BlackRock Advisors (UK) Limited 7179687 0.49
Levin Capital Strategies, L.P. 26081 0
Fidelity Management & Research Company LLC 43778850 2.48
Fidelity SelectCo, LLC 12369290 0.7
UBS Asset Management 3093122 0.18
T. Rowe Price 13698044 0.78
Invesco Capital Management LLC 2772994 0.16

Содержится в ETF

ETF Доля, %
Health Care Select Sector SPDR Fund 4.13

Похожие компании

Описание AbbVie

On October 19, 2011, Abbott Laboratories announced its plan to separate into two publicly traded companies. The «new» Abbott Laboratories would specialize in diversified products including medical devices, diagnostic equipment and nutrition products, while AbbVie would operate as a research-based pharmaceutical manufacturer